川宁生物股价涨5.7%，易方达基金旗下1只基金位居十大流通股东，持有1366.94万股浮盈赚取806.5万元

Group 1 - The core point of the news is that Chuaning Bio has seen a stock price increase of 5.7%, reaching 10.94 yuan per share, with a trading volume of 1.92 billion yuan and a market capitalization of 24.397 billion yuan as of January 6 [1] - Chuaning Bio, established on December 10, 2010, and listed on December 27, 2022, is located in the Yili Kazakh Autonomous Prefecture of Xinjiang and focuses on the research and industrialization of biological fermentation technology [1] - The company's main business revenue composition is 92.81% from pharmaceutical intermediates and 7.19% from other supplementary sources [1] Group 2 - Among the top ten circulating shareholders of Chuaning Bio, E Fund's Chuangye ETF (159915) reduced its holdings by 2.21% to 13.6694 million shares, resulting in a floating profit of approximately 8.065 million yuan [2] - E Fund's Chuangye ETF was established on September 20, 2011, with a current scale of 110.2 billion yuan, achieving a year-to-date return of 2.86% and a one-year return of 65.9% [2] - The fund manager, Cheng Xi, has a tenure of 9 years and 247 days, with a total asset scale of 250.121 billion yuan, while the other manager, Liu Shurong, has a tenure of 8 years and 175 days, managing assets of 139.916 billion yuan [3]